APA

Cattaneo D., Cossu M. V., Fucile S., Riva A., Baldelli S., Meraviglia P., Landonio S., Impagnatiello C., Resnati C., Galli M., Clementi E., Capetti A., Rizzardini G. & Gervasoni C. (20150709). Comparison of the pharmacokinetics of raltegravir given at 2 doses of 400 mg by swallowing versus one dose of 800 mg by chewing in healthy volunteers: a randomized, open-label, 2-period, single-dose, crossover phase 1 study. : Therapeutic drug monitoring.

Chicago

Cattaneo Dario, Cossu Maria V, Fucile Serena, Riva Agostino, Baldelli Sara, Meraviglia Paola, Landonio Simona, Impagnatiello Caterina, Resnati Chiara, Galli Massimo, Clementi Emilio, Capetti Amedeo, Rizzardini Giuliano and Gervasoni Cristina. 20150709. Comparison of the pharmacokinetics of raltegravir given at 2 doses of 400 mg by swallowing versus one dose of 800 mg by chewing in healthy volunteers: a randomized, open-label, 2-period, single-dose, crossover phase 1 study. : Therapeutic drug monitoring.

Harvard

Cattaneo D., Cossu M. V., Fucile S., Riva A., Baldelli S., Meraviglia P., Landonio S., Impagnatiello C., Resnati C., Galli M., Clementi E., Capetti A., Rizzardini G. and Gervasoni C. (20150709). Comparison of the pharmacokinetics of raltegravir given at 2 doses of 400 mg by swallowing versus one dose of 800 mg by chewing in healthy volunteers: a randomized, open-label, 2-period, single-dose, crossover phase 1 study. : Therapeutic drug monitoring.

MLA

Cattaneo Dario, Cossu Maria V, Fucile Serena, Riva Agostino, Baldelli Sara, Meraviglia Paola, Landonio Simona, Impagnatiello Caterina, Resnati Chiara, Galli Massimo, Clementi Emilio, Capetti Amedeo, Rizzardini Giuliano and Gervasoni Cristina. Comparison of the pharmacokinetics of raltegravir given at 2 doses of 400 mg by swallowing versus one dose of 800 mg by chewing in healthy volunteers: a randomized, open-label, 2-period, single-dose, crossover phase 1 study. : Therapeutic drug monitoring. 20150709.